Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Publication save search
DHT Holdings, Inc. today announced the publication of its 2023 Sustainability Report
Published: 2024-04-23 (Crawled : 20:00) - globenewswire.com
DHT | $11.33 1.25% 0.0% 1.2M
|
Transportation
| Email alert
Add to watchlist
report publication today
Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
Published: 2024-04-23 (Crawled : 12:30) - globenewswire.com
ARTL | News | $1.3004 1.87% 15K
|
Health Technology
|
| O: 0.77%
H: 2.29%
C: 0.0%
cancer publication therapy
HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML)
Published: 2024-04-23 (Crawled : 07:00) - prnewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
| Email alert
Add to watchlist
publication treatment research preclinical for leukemia
XORTX Announces Publication of Key Research in ADPKD
Published: 2024-04-22 (Crawled : 11:00) - globenewswire.com
XRTX | News | $2.88 -2.41% 8.3K
|
Mining, Quarrying, and Oil and ...
| Email alert
Add to watchlist
publication research key adpkd
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
Published: 2024-04-18 (Crawled : 14:00) - biospace.com/
CYBN | $0.355 -1.5% 0.0% 2.9M
|
n/a
|
| O: -2.0%
H: 0.0%
C: 0.0%
publication research
Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor Cancers
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
PVCT 4 | $0.1948 -15.0% 63K
|
Manufacturing
| Email alert
Add to watchlist
rose publication tumor preclinical for
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
CMMB | $0.66 0.02% 0.02% 7.2K
|
Manufacturing
|
| O: -3.38%
H: 0.0%
C: 0.0%
ccl24 disease association publication sclerosis
Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®
Published: 2024-04-17 (Crawled : 22:00) - biospace.com/
EOLS | $11.69 -0.26% -0.26% 410K
|
Health Technology
|
| O: -1.49%
H: 0.0%
C: 0.0%
jeuveau publication for study
atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
Published: 2024-04-17 (Crawled : 11:00) - globenewswire.com
ATAI | $1.97 5.35% 5.08% 1.2M
|
Manufacturing
|
| O: 4.87%
H: 0.0%
C: 0.0%
bpl-003 life publication sciences study
Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation
Published: 2024-04-11 (Crawled : 00:00) - biospace.com/
NTRA | News M | $91.07 2.78% 2.7% 1.1M
|
Health Services
|
| O: -0.36%
H: 0.0%
C: 0.0%
kidney publication study
Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive
Published: 2024-04-11 (Crawled : 12:00) - globenewswire.com
DARE | $0.306 3.62% 3.5% 320K
|
Health Technology
|
| O: 1.36%
H: 0.68%
C: -0.64%
ovaprene test positive bioscience publication contraceptive contraception study
Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing
Published: 2024-04-11 (Crawled : 12:00) - globenewswire.com
BNGO | $0.7928 4.23% 4.06% 820K
|
Health Technology
|
| O: 3.88%
H: 0.0%
C: -3.74%
publication leukemia
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
ATHA | $2.035 -2.63% -2.7% 85K
|
Health Technology
|
| O: 4.9%
H: 6.03%
C: 3.11%
fosgonimeton pharma disease alzheimer’s publication treatment preclinical
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is VitalLack of early symptom improvement is not predictive of final responder status
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
STIM | $3.865 3.34% 3.23% 41K
|
Health Technology
|
| O: 1.18%
H: 4.28%
C: 1.17%
publication treatment
Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma
Published: 2024-04-10 (Crawled : 20:00) - globenewswire.com
SGHT | $5.64 5.03% 4.79% 130K
|
|
| O: 0.17%
H: 6.78%
C: 2.69%
GKOS | $101.1 2.17% 0.0% 350K
|
Health Technology
|
| O: 0.75%
H: 0.51%
C: -1.19%
omni glaucoma publication sciences system technology study
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04
Published: 2024-04-10 (Crawled : 14:30) - biospace.com/
ADIL | News | $1.73 -8.95% -9.83% 440K
|
Health Technology
|
| O: 123.48%
H: 0.0%
C: 0.0%
ad04 publication pharmaceuticals trial
Osisko Announces Publication of 2023 Sustainability Report
Published: 2024-04-10 (Crawled : 13:00) - globenewswire.com
OR | $15.78 2.2% 0.0% 690K
|
Non-Energy Minerals
|
| O: -3.57%
H: 2.01%
C: 2.01%
report publication
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
Published: 2024-04-10 (Crawled : 12:30) - globenewswire.com
ADIL | News | $1.73 -8.95% -9.83% 440K
|
Health Technology
|
| O: 123.48%
H: 0.0%
C: 0.0%
ad04 alcohol publication treatment pharmaceuticals for trial potential
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Published: 2024-04-10 (Crawled : 12:30) - globenewswire.com
STIM | $3.865 3.34% 3.23% 41K
|
Health Technology
|
| O: 1.18%
H: 4.28%
C: 1.17%
publication treatment
BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS
Published: 2024-04-10 (Crawled : 10:00) - prnewswire.com
BCLI A | $0.531 -1.69% -1.71% 170K
|
Health Technology
|
| O: -20.14%
H: 0.0%
C: 0.0%
als biomarker publication cell trial therapeutics
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.